Man who let snakes bite him 200 times spurs new antivenom hope
There are around 600 venomous snakes in the world today. (AFP pic)
PARIS : Tim Friede was feeling particularly down on the day after the Sept 11 attacks, so he went to his basement and let two of the world's deadliest snakes bite him.
Four days later, he woke up from a coma.
'I know what it feels like to die from snakebite,' Friede told AFP via video call from his home in the small US town of Two Rivers, Wisconsin.
This experience might put most people off snakes entirely, but Friede simply vowed to be more careful next time.
From 2000 to 2018, he allowed himself to be bitten by snakes more than 200 times. He also injected himself with their venom over 650 times.
Friede endured this pain because he wanted to achieve total immunity to venom, a practice called mithridatism which should not be tried at home.
After a couple of years, Friede started to believe he could be the basis for a better kind of antivenom. The former truck mechanic, who does not have a university degree, long struggled to be taken seriously by scientists.
But last month, a study published in the prestigious Cell journal showed that antibodies from his blood protect against a range of snake venom.
The researchers now hope Friede's hyper-immunity could even lead to the development of a universal antivenom.
This would fill a major need, because currently most antivenoms only cover one or a few of the world's 600 venomous snakes.
Up to 138,000 people are killed by snakebites a year, while 400,000 suffer amputations or other disabilities, according to the World Health Organization.
These figures are believed to be vastly underestimated because snakebite victims typically live in poorer, remote areas.
'Pain every time'
Friede's first bite was from a harmless garter snake when he was five years old.
'I was afraid, I cried, I ran away,' said Friede, now 57.
Then he started bringing snakes home and hiding them in pickle jars. His mother sought counselling, but his interest in snakes persisted.
Things escalated after Friede attended a class that taught him how to 'milk' snakes for their venom.
How antivenom is made has changed little over the last 125 years.
Small doses of snake venom are injected into animals such as horses, which produce antibodies that can be extracted and used as antivenom.
However this antivenom usually only works for bites from that particular species of snake – and it includes other antibodies from horse that can cause serious side-effects including anaphylactic shock.
'I thought, well, if they make antivenom in horses, why can't I just use myself as a primate?' Friede said.
He started working through the venom from all the deadly species he could get his hands on, such as cobras, taipans, black mambas and rattlesnakes.
'There is pain every time,' he said.
'Proud'
For years, the scientists he contacted to take advantage of his immunity refused to bite.
Then in 2017, immunologist Jacob Glanville, who previously worked on universal vaccines, turned his attention towards antivenom.
Glanville told AFP he had been looking for 'a clumsy snake researcher who'd been bit accidentally a couple times,' when he came across a video of Friede taking brutal back-to-back snake bites.
When they first spoke, Glanville said he told Friede: 'I know this is awkward, but I would love to get my hands on some of your blood.'
'I've been waiting for this call for a long time,' came the response, Glanville said.
The antivenom described in the Cell paper includes two antibodies from Friede's blood, as well as a drug called varespladib.
It offered mice full protection against 13 of the 19 snake species tested, and partial protection for the remaining six.
The researchers hope a future cocktail will cover far more snakes – particularly vipers – with further trials planned on dogs in Australia.
Timothy Jackson of the Australian Venom Research Unit praised the immunological research, but questioned whether a human needed to be involved, pointing to synthetically developed antibodies.
Glanville said the ultimate goal of his US-based firm Centivax was to develop a universal antivenom administered by something like an EpiPen, potentially produced in India to keep the costs down.
Friede said he was 'proud' to have made a 'small difference' in medical history.
Now working for Centivax, Friede stopped self-inflicting himself with venom in 2018 to save the firm from liability issues.
But he hopes to get bitten by snakes again in the future.
'I do miss it,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
2 days ago
- Malay Mail
Cancer Diaries: Cancer-free for now but the journey isn't over
JUNE 11 — I never thought I would have something in common with Jamal Yunos but here it is — our cancer treatments worked. Unlike Jamal, I don't have to deal with pending court judgements but also have quite a bit more treatment to go. The pathology report from my surgery, from testing the lesion and lymph nodes removed, show no residual cancer. I knew the odds of this happening was only 50/50 because hormone-positive tumours don't always respond well to chemotherapy but mine did. It also meant all the effort put into crowdfunding for the (very expensive) drug Perjeta was not for naught and neither were the frequent hospital trips, the constant stabbing of needles, losing my hair and discovering just how far my pain tolerance stretched. I'm not out of the woods yet as I have another 13 cycles of Herceptin to endure, which will be administered every three weeks. Going nuclear (literally) There will be another appointment soon to prepare me for radiotherapy and that will start in a month or so. I found it very humorous that my oncologist as well as the nice staffers in radiology asked me if I could raise my arms — this is the gauge for how well I can endure the treatment. My physiotherapist was also surprised I had near-full range of motion in my arms because my legs are a whole other story. He said my calves and hips were very stiff, and I needed to put work into strengthening my glute muscles as well as do more exercises involving my shoulder blades. As of now getting up or out of a seat requires a quick prayer, a sharp inhale and resigning myself to painful, awkward hobbling. Still, at least I won't be having periods as I am now on the estrogen suppressant drug Tamoxifen, which means I am in a chemically induced menopause. This would perhaps be devastating for a much younger woman or one hoping to conceive, but I am at the age where I will only want to hold a baby if I can give it back. I have also been irritable and prone to sensory overload since I was a small child so I often joke that I would be little different come menopause. Chemotherapy has also made me rather heat intolerant to the point I won't be able to tell if I'm having a hot flash or if it's just Malaysian weather. While I come across as being rather blasé, there is a real need for women to be given better advice on how to deal with perimenopause and what comes after. Reddit has informed me that it's not just our hormones changing — menopausal women face changes to their genitalia including, sometimes, the complete disappearance of the labia minora. At the same time I wistfully daydream about flying somewhere, anywhere just to clear my head but with a new Covid variant (again) and my legs made of lead, I think next year is a safer bet.— AFP pic I'm not going to explain what that is, look it up. To have cancer and also be dealing with induced menopause would be hard on any woman so if you know someone going through it, please be kind. I'm still on hospitalisation leave and while my surgery incision is healing well, I'm still not very mobile. There are many questions I would love to ask my body. Why is the arm on the side that doesn't have cancer less mobile than the cancer-affected side? I wake up every morning with my arms sore as though I spent the entire day before working on my butterfly stroke. Why is my ankle swollen? Why are my eyelashes and nose hair still not growing back though the top of my head now feels like a kiwi fruit, coated with downy short hairs? At the same time I wistfully daydream about flying somewhere, anywhere just to clear my head but with a new Covid variant (again) and my legs made of lead, I think next year is a safer bet. My knees are currently vetoing even the thought of visiting my favourite cafe in Melaka as I find even my purse too heavy to carry around. Next week I'll be seeing my surgeon for the usual hospital adventure where I wait two hours to see a doctor for 10 minutes. For now, though, life is as good as it gets, my cat has forgiven me and is back to yelling at me for treats, and I feel as ever, very lucky, very blessed and very grateful. Thank you for coming along on the journey and your support, whatever form it took. * This is the personal opinion of the columnist.
Free Malaysia Today
3 days ago
- Free Malaysia Today
Man who let snakes bite him 200 times spurs new antivenom hope
There are around 600 venomous snakes in the world today. (AFP pic) PARIS : Tim Friede was feeling particularly down on the day after the Sept 11 attacks, so he went to his basement and let two of the world's deadliest snakes bite him. Four days later, he woke up from a coma. 'I know what it feels like to die from snakebite,' Friede told AFP via video call from his home in the small US town of Two Rivers, Wisconsin. This experience might put most people off snakes entirely, but Friede simply vowed to be more careful next time. From 2000 to 2018, he allowed himself to be bitten by snakes more than 200 times. He also injected himself with their venom over 650 times. Friede endured this pain because he wanted to achieve total immunity to venom, a practice called mithridatism which should not be tried at home. After a couple of years, Friede started to believe he could be the basis for a better kind of antivenom. The former truck mechanic, who does not have a university degree, long struggled to be taken seriously by scientists. But last month, a study published in the prestigious Cell journal showed that antibodies from his blood protect against a range of snake venom. The researchers now hope Friede's hyper-immunity could even lead to the development of a universal antivenom. This would fill a major need, because currently most antivenoms only cover one or a few of the world's 600 venomous snakes. Up to 138,000 people are killed by snakebites a year, while 400,000 suffer amputations or other disabilities, according to the World Health Organization. These figures are believed to be vastly underestimated because snakebite victims typically live in poorer, remote areas. 'Pain every time' Friede's first bite was from a harmless garter snake when he was five years old. 'I was afraid, I cried, I ran away,' said Friede, now 57. Then he started bringing snakes home and hiding them in pickle jars. His mother sought counselling, but his interest in snakes persisted. Things escalated after Friede attended a class that taught him how to 'milk' snakes for their venom. How antivenom is made has changed little over the last 125 years. Small doses of snake venom are injected into animals such as horses, which produce antibodies that can be extracted and used as antivenom. However this antivenom usually only works for bites from that particular species of snake – and it includes other antibodies from horse that can cause serious side-effects including anaphylactic shock. 'I thought, well, if they make antivenom in horses, why can't I just use myself as a primate?' Friede said. He started working through the venom from all the deadly species he could get his hands on, such as cobras, taipans, black mambas and rattlesnakes. 'There is pain every time,' he said. 'Proud' For years, the scientists he contacted to take advantage of his immunity refused to bite. Then in 2017, immunologist Jacob Glanville, who previously worked on universal vaccines, turned his attention towards antivenom. Glanville told AFP he had been looking for 'a clumsy snake researcher who'd been bit accidentally a couple times,' when he came across a video of Friede taking brutal back-to-back snake bites. When they first spoke, Glanville said he told Friede: 'I know this is awkward, but I would love to get my hands on some of your blood.' 'I've been waiting for this call for a long time,' came the response, Glanville said. The antivenom described in the Cell paper includes two antibodies from Friede's blood, as well as a drug called varespladib. It offered mice full protection against 13 of the 19 snake species tested, and partial protection for the remaining six. The researchers hope a future cocktail will cover far more snakes – particularly vipers – with further trials planned on dogs in Australia. Timothy Jackson of the Australian Venom Research Unit praised the immunological research, but questioned whether a human needed to be involved, pointing to synthetically developed antibodies. Glanville said the ultimate goal of his US-based firm Centivax was to develop a universal antivenom administered by something like an EpiPen, potentially produced in India to keep the costs down. Friede said he was 'proud' to have made a 'small difference' in medical history. Now working for Centivax, Friede stopped self-inflicting himself with venom in 2018 to save the firm from liability issues. But he hopes to get bitten by snakes again in the future. 'I do miss it,' he said.
The Star
4 days ago
- The Star
Man who let snakes bite him 200 times spurs new antivenom hope
SOUTH-EAST ASIA/PARIS (AFP): Tim Friede was feeling particularly down on the day after the September 11 attacks, so he went to his basement and let two of the world's deadliest snakes bite him. Four days later, he woke up from a coma. "I know what it feels like to die from snakebite," Friede told AFP via video call from his home in the small US town of Two Rivers, Wisconsin. This experience might put most people off snakes entirely, but Friede simply vowed to be more careful next time. From 2000 to 2018, he allowed himself to be bitten by snakes more than 200 times. He also injected himself with their venom over 650 times. Friede endured this pain because he wanted to achieve total immunity to venom, a practice called mithridatism which should not be tried at home. After a couple of years, Friede started to believe he could be the basis for a better kind of antivenom. The former truck mechanic, who does not have a university degree, long struggled to be taken seriously by scientists. But last month, a study published in the prestigious Cell journal showed that antibodies from his blood protect against a range of snake venom. The researchers now hope Friede's hyper-immunity could even lead to the development of a universal antivenom. This would fill a major need, because currently most antivenoms only cover one or a few of the world's 600 venomous snakes. Up to 138,000 people are killed by snakebites a year, while 400,000 suffer amputations or other disabilities, according to the World Health Organization. These figures are believed to be vastly underestimated because snakebite victims typically live in poorer, remote areas. - 'Pain every time' - Friede's first bite was from a harmless garter snake when he was five years old. "I was afraid, I cried, I ran away," said Friede, now 57. Then he started bringing snakes home and hiding them in pickle jars. His mother sought counselling, but his interest in snakes persisted. Things escalated after Friede attended a class that taught him how to "milk" snakes for their venom. How antivenom is made has changed little over the last 125 years. Small doses of snake venom are injected into animals such as horses, which produce antibodies that can be extracted and used as antivenom. Researchers hope Friede's hyper-immunity could even lead to the development of a universal anti-venom. -- PHOTO: AFP However this antivenom usually only works for bites from that particular species of snake -- and it includes other antibodies from horse that can cause serious side-effects including anaphylactic shock. "I thought, well, if they make antivenom in horses, why can't I just use myself as a primate?" Friede said. He started working through the venom from all the deadly species he could get his hands on, such as cobras, taipans, black mambas and rattlesnakes. "There is pain every time," he said. - 'Proud' - For years, the scientists he contacted to take advantage of his immunity refused to bite. Then in 2017, immunologist Jacob Glanville, who previously worked on universal vaccines, turned his attention towards antivenom. Glanville told AFP he had been looking for "a clumsy snake researcher who'd been bit accidentally a couple times," when he came across a video of Friede taking brutal back-to-back snake bites. When they first spoke, Glanville said he told Friede: "I know this is awkward, but I would love to get my hands on some of your blood." "I've been waiting for this call for a long time," came the response, Glanville said. The antivenom described in the Cell paper includes two antibodies from Friede's blood, as well as a drug called varespladib. It offered mice full protection against 13 of the 19 snake species tested, and partial protection for the remaining six. The researchers hope a future cocktail will cover far more snakes -- particularly vipers -- with further trials planned on dogs in Australia. Timothy Jackson of the Australian Venom Research Unit praised the immunological research, but questioned whether a human needed to be involved, pointing to synthetically developed antibodies. Glanville said the ultimate goal of his US-based firm Centivax was to develop a universal antivenom administered by something like an EpiPen, potentially produced in India to keep the costs down. Friede said he was "proud" to have made a "small difference" in medical history. Now working for Centivax, Friede stopped self-inflicting himself with venom in 2018 to save the firm from liability issues. But he hopes to get bitten by snakes again in the future. "I do miss it," he said. - AFP
